TY  - GEN
AU  - Al-Mousa,Hamoud
AU  - Al-Shammari,Zamil
AU  - Al-Ghonaium,Abdulaziz
AU  - Al-Dhekri,Hasan
AU  - Al-Muhsen,Saleh
AU  - Al-Saud,Bander
AU  - Arnaout,Rand
AU  - Al-Seraihy,Amal
AU  - Al-Jefri,Abdullah
AU  - Al-Ahmari,Ali
AU  - Ayas,Mouhab
AU  - El-Solh,Hassan
TI  - Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency
SN  - 1523-6536
PY  - 2011///0113
KW  - Blood Cell Count
KW  - Bone Marrow Transplantation
KW  - adverse effects
KW  - Child
KW  - Child, Preschool
KW  - Disease-Free Survival
KW  - Female
KW  - Graft Survival
KW  - immunology
KW  - Graft vs Host Disease
KW  - diagnosis
KW  - HLA Antigens
KW  - Hematopoietic Stem Cell Transplantation
KW  - Histocompatibility
KW  - Histocompatibility Antigens Class II
KW  - Humans
KW  - Immunoglobulin G
KW  - blood
KW  - Immunologic Deficiency Syndromes
KW  - Infant
KW  - Infant, Newborn
KW  - Lymphocyte Count
KW  - Lymphocytes
KW  - cytology
KW  - Male
KW  - Myeloablative Agonists
KW  - therapeutic use
KW  - Retrospective Studies
KW  - Transplantation Chimera
KW  - Transplantation Conditioning
KW  - methods
KW  - Transplantation, Homologous
KW  - Treatment Outcome
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1016/j.bbmt.2010.01.002
ER  -